EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Exposure to androgen deprivation therapy and risk of anastomotic leakage after colorectal cancer surgery

Martin Rutegård, Isac Norrgård, John Moshtaghi-Svensson, Jaana Hagström, Ida Hed Myrberg, Anna Lantz, Suvi Rasilainen, Caroline Nordenvall, Malin Sund

Colorectal Disease · 2025-06 · 27 (6)

DOI: 10.1111/codi.70126 ↗

At a glance

Journal article in Colorectal Disease, published online on 2025-06-03. Written by Martin Rutegård and 8 co-authors. Institution: Department of Diagnostics and Intervention, Surgery, Umeå University, Umeå, Sweden. Major MEDLINE topics: Anastomotic Leak, Colorectal Neoplasms, Androgen Antagonists. Cited 3 times so far (Crossref); 25 references. The full text is freely available (open access, CC BY 4.0). Funded by: Cancerföreningen i Stockholm, Svenska Läkaresällskapet, Region Västerbotten.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Aim

The risk of anastomotic leakage after colorectal cancer surgery is higher in men, regardless of the anatomical location. Previous studies suggest that this might be due to hormonal differences. The aim of this work was to investigate whether androgen deprivation therapy influenced the incidence of anastomotic leakage.

Method

This is a nationwide registry‐based study of men operated on between 2007 and 2021 for colorectal cancer with an anastomosis. Exposure to androgen deprivation therapy (prescribed drugs or surgical castration) was related to anastomotic leakage using mixed‐effects logistic regression models. Two control groups were formed: one without and one with prostate cancer but without androgen deprivation. To study the potential target for androgen effect in intestinal tissue, androgen receptor expression was evaluated using immunohistochemistry in a smaller independent cohort to compare receptor expression in relation to leakage.

Results

Some 24 611 men were included in the registry study, of whom 2.4% were exposed to androgen deprivation therapy. In this exposed group, compared with unexposed men with and without prostate cancer, respectively, leak rates were 3.7%, 5.6% and 5.8%, respectively. After adjustment, a nonsignificant reduction of anastomotic leakage in the exposed group was detected (OR 0.70, 95% CI 0.45–1.09) compared with men without prostate cancer. Tissue expression of androgen receptor was very low among patients with and without leakage, albeit with a trend of higher expression among the latter.

Conclusion

Anastomotic leakage rates might be lower in men exposed to androgen deprivation therapy before surgery for colorectal cancer, although this finding must be interpreted cautiously. Effects on anastomotic healing do not seem to be mediated through classical androgen receptor signalling in the intestine.

Subjects

MeSH terms (MEDLINE)

Anastomotic LeakColorectal NeoplasmsAndrogen AntagonistsHumansMaleAgedMiddle AgedRegistriesReceptors, AndrogenRisk FactorsProstatic NeoplasmsIncidenceAnastomosis, SurgicalLogistic Models

Author keywords

anastomosishormonesleakmenoperationreceptor

Substances

Androgen AntagonistsReceptors, Androgen

Authors and institutions

  • Department of Diagnostics and Intervention, Surgery, Umeå University, Umeå, Sweden.
  • Department of Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
  • Department of Oral Pathology and Radiology, University of Turku and Turku University Hospital, Turku, Finland.
  • Department of Pathology, Helsinki University and Helsinki University Hospital, Helsinki, Finland.
  • Translational Cancer Research Program Unit, University of Helsinki, Helsinki, Finland.

Funding

  • Cancerföreningen i Stockholm
  • Svenska Läkaresällskapet
  • Region Västerbotten
  • Swedish Cancer and Allergy Foundation
  • Finska Läkaresällskapet
  • Umeå Universitet
  • Medicinska Understödsföreningen Liv och Hälsa

Cite

APA

Rutegård, M., Norrgård, I., Moshtaghi-Svensson, J., Hagström, J., Myrberg, I. H., Lantz, A., Rasilainen, S., Nordenvall, C., & Sund, M. (2025). Exposure to androgen deprivation therapy and risk of anastomotic leakage after colorectal cancer surgery. Colorectal Disease, 27(6). https://doi.org/10.1111/codi.70126

Vancouver

Rutegård M, Norrgård I, Moshtaghi-Svensson J, Hagström J, Myrberg IH, Lantz A, et al. Exposure to androgen deprivation therapy and risk of anastomotic leakage after colorectal cancer surgery. Colorectal Disease. 2025;27(6). doi:10.1111/codi.70126

BibTeX
@article{Rutegrd2025,
  author = {Rutegård, Martin and Norrgård, Isac and Moshtaghi-Svensson, John and Hagström, Jaana and Myrberg, Ida Hed and Lantz, Anna and Rasilainen, Suvi and Nordenvall, Caroline and Sund, Malin},
  title = {Exposure to androgen deprivation therapy and risk of anastomotic leakage after colorectal cancer surgery},
  journal = {Colorectal Disease},
  year = {2025},
  volume = {27},
  number = {6},
  doi = {10.1111/codi.70126}
}
Start for free →